ACT With CF Self-Help Toolkit

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThomas Jefferson University

About this trial

Acceptance and Commitment Therapy (ACT) tailored to meet the needs of adults living with cystic fibrosis (ACT with CF) is a newer form of talk therapy that has been shown to reduce anxiety \& depression and improve psychological flexibility, and value-based living. The investigators are now trying to find out whether a self-help version of this treatment (ACT with CF - Self Help Toolkit) is also effective in reducing anxiety and depression and improving psychological flexibility and value-based living in adults with CF.

Adults with cystic fibrosis are at increased risk for anxiety and depression. This study examines whether a patient-facing therapy, ACT with CF - Self Help Toolkit can help to reduce anxiety and depression among adults with CF. This treatment can be accessed on the participant's smartphone.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 years or older

Existing diagnosis of cystic fibrosis

PHQ-9 score >4 or GAD-7 score >4

Disqualifiers

History of suicide attempts or acute suicidal ideation on clinical assessment

Presence of psychotic disorder or symptoms

Presence of psychiatric disorders that interfere with participation in the study, judged by the study or treating clinician

Presence of other medical conditions that interfere with participation in the study, judged by the study or treating clinician

Trial design

Design model

Parallel

Treatments tested in this trial

  • ACT with CF Self-Help Toolkit

    Behavioral

    The ACT with CF Self-Help Toolkit will include 6 main modules, each with 3 or 4 kernels, which will be short videos, in which participants will learn new ways to manage uncomfortable experiences and feelings (e.g., anxiety, depression) and to engage in positive behaviors. These videos are based on the main interventions in our ACT with CF individual therapy protocol. For example, the first main module focuses on how the participant wants to live their life (Values Clarification Intervention), and the kernels in this module are 1-3 minute video clips demonstrating different ways to figure this out (Card Sort, 70th Birthday exercise, accessing barriers). This intervention is directly adapted from the ACT with CF manual, which has been studied previously in several forms and studies.

  • Waitlist

    Other intervention

    Participants in the waitlist condition will wait for six weeks before receiving the ACT with CF Self-Help Toolkit

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Immediate TreatmentExperimental treatment 1 intervention
Group B: WaitlistOther 2 interventions

Trial outcomes

Primary outcomes

1

Anxiety

Anxiety as measured by the Beck Anxiety Inventory (Range 0-63), with higher values indicating higher anxiety.

Time frame
at each time point (baseline, 6 weeks, 3 months)
2

Depression

Depression as measured by the Beck Depression Inventory II (Range 0-63), with higher values indicating more severe depression symptoms.

Time frame
at each time point (baseline, 6 weeks, 3 months)
3

Psychological Flexibility

Psychological flexibility as measured by the Acceptance and Action Questionnaire II (Range 7-49), with higher values indicating less flexibility.

Time frame
at each time point (baseline, 6 weeks, 3 months)
4

Cognitive Fusion

Cognitive fusion as measured by the Cognitive Fusion Questionnaire 13 (Range 7-91), with higher values indicating more intense cognitive fusion.

Time frame
at each time point (baseline, 6 weeks, 3 months)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Thomas Jefferson University

Lead sponsor

Boomer Esiason Foundation

Collaborator